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Igniting thermogenesis within white adipose tissue (i.e., promoting expression and activity of the uncoupling
protein UCP1) has attractedmuch interest. Numerous ‘‘browning agents’’ have now been described (gene ab-
lations, transgenes, foodcomponents, drugs, environments, etc.). The impliedactionofbrowningagents is that
they increase UCP1, through this heat production, leading to slimming. Here, we particularly point to the pos-
sibility that causeandeffectmayonoccasionbe the reverse: browningagentsmaydisrupt, for example, the fur,
leading to increased heat loss, increased thermogenic demand to counteract this heat loss, and thus, through
sympathetic nervous system activation, to enhanced UCP1 expression in white (and brown) adipose tissues.To harness the thermogenic power of the uncoupling protein
UCP1—and thus its ability to nullify the effects of extra energy
intake—has attractive perspectives for human health. Not only
would it enable us to stay or even to become slim even if an
excess of food were eaten, but it would also counteract comor-
bidities such as type 2 diabetes. Particularly, recent years have
seen an intense interest in the ability to ‘‘brown’’ what have tradi-
tionally been seen as white adipose tissue depots. The idea is
to place the combustion machinery (i.e., UCP1) directly in the
excess fat supply.
Until recently (Nedergaard et al., 2007), it was common wis-
dom that adult humans do not possess active brown adipose tis-
sue. Therefore, the concept that certain white depots could
develop brownish characteristics had a great advantage: this
way of translating the power of brown fat into human health ap-
peared much more feasible than reintroducing true brown fat
into adult men. Additionally, observations that very large in-
creases (100-fold) in the mRNA levels of UCP1 could be induced
in rodents in certain white adipose tissue depots had made the
browning process very attractive for therapeutic exploration.
In this Perspective,wediscuss someof theburning issues con-
cerning the browning process.Wepragmatically definebrowning
asanysignificantly increasedUCP1expressionat themRNA level
occurring inwhat arenormally consideredaswhiteadipose tissue
depots. The resulting cells that express UCP1may be referred to
as beige (Ishibashi and Seale, 2010), brite (Petrovic et al., 2010),
convertible (Loncar, 1991), ectopic (Lehr et al., 2009), inducible
(Lee et al., 2011), or recruitable (Schulz et al., 2013). (This latter
term is unfortunately often misread to indicate that classical
brown adipose tissue is not recruitable. However, the opposite
is true: classical brown adipose tissue is very recruitable in the
sense that it increases its thermogenic capacity some 5-fold
from 20C to 5C [Nedergaard and Cannon, 2013]). Here, we
use a simple ‘‘browning’’ terminology.
Presently, Almost Everything Browns White
Adipose Tissue
Some 50–100 different treatments have been demonstrated to
induce browning: food components, drug substances, trans-
genes, gene knockouts, and enhanced or deteriorated living396 Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc.conditions. The list of browning agents is growing rapidly. For
simplicity, we refer to any of these compounds or genetic mod-
ifications or ways of living as ‘‘browning agents.’’ Thus, it should
be kept in mind that the expression in this Perspective includes
factors of a much broader nature than just drug substances.
Several reviews have recently carefully listed these agents
(Bonet et al., 2013; Wu et al., 2013), and we will not duplicate
these efforts. Rather, we would like to suggest some ‘‘unifying
hypotheses’’ for understanding why such a broad variety of
agents can all result in browning. Because of the very rapid
growth of literature, this Perspective cannot attempt to be
comprehensive, and we apologize if we have overlooked contri-
butions with a principal impact on the issues discussed.
Browning as a Sympathetic Event
The first report of the browning phenomenon is that of Young
et al. (1984). The authors observed that areas in the parametrial
adipose depot developed brown-fat characteristics when mice
were acclimated to cold. Given that recruitment in classical
brown adipose tissue is due to chronic stimulation by norepi-
nephrine released from the sympathetic nerves innervating the
tissue (Cannon and Nedergaard, 2004), the possibility that
browning could also be induced by chronic adrenergic stimula-
tion was examined. Indeed, chronic treatment with a b3-adren-
ergic agent led to browning (Cousin et al., 1992; Ghorbani
et al., 1997; Ghorbani and Himms-Hagen, 1997). In mice without
b3 adrenoceptors, browning was barely induced (Jimenez et al.,
2003). Correspondingly, overexpression of b1 adrenoceptors in
white adipocytes was sufficient to induce browning (Soloveva
et al., 1997). Thus, adrenergic stimulation of white adipose tissue
definitely induces the browning process. Here, we examine to
what degree this norepinephrine-induced, and thus centrally
mediated, process is sufficient to explain the effect of (some
of) the browning agents.
A Hierarchical Activation System
On the basis of the divergent physiological functions we normally
ascribe to brown versus white adipose tissue, it would be ex-
pected that the innervation of these tissues would be qualita-
tively very different. Particularly, it would be thought that the
Figure 1. The Hierarchical Organization of the Activation of Brown
and White Adipose Tissues
The nerve pathways stimulating brown and white adipose tissues have similar
origins in the brain, but they are differently controlled; thus, with increasing
exposure to cold, the nerves to brown fat will initially become active, but, with
continued decreasing temperatures, the nerves to white-fat depots may also
be successively engaged. The receiving depots contain different fractions of
cells able to respond to norepinephrine stimulation with an increase in UCP1
gene expression, as indicated. The browning white adipose tissues are often
those referred to as ‘‘subcutaneous’’ adipose tissue depots; the one normally
studied is the inguinal depot. The depots least able to respond are those often
referred to as ‘‘visceral’’; the one normally studied is the epididymal depot.
Thus, with increasing intensity of sympathetic stimulation, browning of the
inguinal depot will be augmented in addition to recruitment of classical brown
adipose tissue.
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distinct. However, studies where the innervation to brown versus
white adipose tissue depots has been delineated tend not to
identify distinct brown- versus white-fat-specific control centers
in the brain (Bamshad et al., 1998, 1999). Basically, this would
mean that an organization exists where similar brain events
would evoke qualitatively similar activation of either tissue
(Figure 1A). Although this is somewhat unexpected in several re-
spects, it makes it possible to understand that browning of white
adipose tissue may not be substantially different from recruit-
ment of classical brown adipose tissue.
The parallel innervation does not mean that the sympathetic
activation occurs to the same degree in different depots. Clas-
sical brown adipose tissue demonstrates small but significant
UCP1 gene expression already at thermoneutrality (z30C).
This may indicate that sympathetic stimulation can occur in the
absence of a thermal signal. White adipose tissue is principally
devoid of UCP1 at thermoneutrality, and cold acclimation leads
to successivebrowning,with someUCP1expression at ‘‘normal’’
animal house temperatures (z20C) and much more in the cold
(z5C) (Walde´net al., 2012). Thus, ahierarchymaybe formulated
wherein increasing central stimulation successively activates first
brown and then white adipose tissue depots. In contrast, exper-
iments with injected adrenergic agents do not show this hierar-
chical system. Such injections directly induce browning with
the bias that injections at normal animal house temperatures
appear to have a much greater (relative) effect on white than
brown adipose tissues. This is because, under normal experi-
mental conditions, the classical brown adipose tissue is already
physiologically adrenergically stimulated and therefore shows
only comparatively modest relative effects of additional stimula-
tion—but these effects may be quantitatively large.
This organization of the system is confirmed by classical ob-
servations that surgical removal of a given brown adipose tissuedepot will result in the activation of other depots (Connolly and
Carnie, 1982; Stephens et al., 1981). Also, in accordance with
this, a substantial reduction of ‘‘classical’’ brown adipose tissue
activity (molecularly introduced by eliminating the bone morpho-
genetic protein [BMP] receptor 1A from brown adipocyte precur-
sors) results in ‘‘compensatory’’ browning of white depots
(Schulz et al., 2013) with a regaining of thermogenic capacity.
Thus, the brain will augment the intensity of nerve activity to
the relevant adipose tissue depots to the exact extent required
to generate the heat needed. If the intensity is sufficiently high,
then browning via physiological means will occur.
It may be wondered whether the UCP1 gene in the white adi-
pose tissue can be induced to be expressed without first being
‘‘unmasked’’ by another process. However, Boyer and Kozak
(1991) observed that there were DNase hypersensitive sites in
the upstream region of the UCP1 gene in both brown and white
adipose tissues. These sites were not seen in nonadipose tis-
sues, implying that the UCP1 gene in white adipose tissue is
already ‘‘open’’ and merely needs, for example, adrenergic stim-
ulation to become expressed. However, there is the difference
that far fewer cells in white than brown adipose tissue have
open UCP1 genes (see the in vitro discussion in the Supplement
Information available online).
All in all, there is no reason to think that browning of white ad-
ipose tissue in the cold is a process that is fundamentally
different from the standard recruitment of brown adipose tissue
in the cold. Thus, it can be explained by increased sympathetic
stimulation of either tissue.
An Efficient, but Very Indirect, Browning Agent: The
Feeling of Cold
Given that the most notable physiological factor leading to
browning is cold, pertinent but infrequently addressed questions
are (1) do (some of) the animals that demonstrate browning feel
cold to a greater extent, and (2) can this be the reason that
browning occurs?
By this, we do not imply that their nervous system should have
been altered by the treatment. Rather, they may experience the
normal surroundings as much colder than do mice not exposed
to the browning agents.
For a mouse, the temperature of a normal animal house is in
itself a cold stress. As seen in Figure 2, at 20C, a mouse loses
so much heat that it needs to increase its heat production (and
thus its food consumption as well) by about 50% in comparison
to the heat production in the thermoneutral zone. This is the case
for a normal wild-type mouse.
If a mouse loses its fur, then much of its insulation will also
disappear. Shaved mice increase their metabolic rate at normal
animal house temperatures by nearly 50% because of the
increased heat loss (Hirata et al., 2011). Similarly, the genetically
nude Balb/c mice have a metabolic rate z80% higher than
normal Balb/c mice (Hirata et al., 2011). We have illustrated the
consequence of this in Figure 2. It can be understood from this
that shaving a mouse living at 20C is equivalent to transferring
an unshaven mouse from 20C to 10C. Also note that, at
20C, the extra metabolism required to counteract the extra
heat loss due to shaving is some 300% of that of the unshaven
mouse. This indicates a requirement for 3-fold more thermogen-
esis in the shaven mouse.Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc. 397
Figure 2. The Effect of Decreased Insulation on the Heat Needed to
Counteract Cooling at Different Temperatures
When the environmental temperature is decreased,mice have to increase their
metabolism in order to compensate for the increased heat lost. The response
follows physical laws for heat transfer and is therefore linear, as illustrated in
the pink triangle; the line extrapolates to body temperature (actual values are
based on data in Golozoubova et al., 2004). The black double arrow indicates
the extra heat necessary for living atz20C as compared to living within the
thermoneutral zone (TNZ), illustrated by the length of the black box. If mice lose
some of their insulation because of (unintended and possibly unobserved)
effects of browning agents, the heat loss at every temperaturewill be higher, as
illustrated by the red area (the values shown are extrapolated from those re-
ported for shaven and for genetically nude mice by Hirata et al., 2011). The
extra heat needed in the nude mice to compensate for the heat loss at 20C
(skin-colored double arrow) is nearly three times as high as in normal mice; this
means that the nudemice experience the environment at 20C as being similar
to that of normal mice at 10C. Therefore, browning of white adipose tissue will
take place for physical reasons. The effect of diminished insulation is also that
the lower limit of the thermoneutral zone moves upward, as illustrated by the
length of the skin-colored box; therefore, in browning-agent-affected animals,
30Cmay no longer be thermoneutral. This way of representingmetabolic data
may be referred to as a Scholander plot (Scholander et al., 1950).
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skin, fur, and hair, can be considered to be fully equivalent to be-
ing exposed to a colder environmental temperature—and cold
is, as discussed above, a strong browning agent. Thus, the perti-
nent question becomes: can (some/any of) the reported brown-
ing effects be explained through mechanisms akin to shaving a
mouse?
We have rather haphazardly examined the literature concern-
ing the effect of some of the browning models on the skin, fur,
and hair phenotypes of the mice. We found—as exemplified
below—that it is not uncommon that the browning effect is asso-
ciated with changes in insulation; strikingly, this is relevant for
some of the most noted browning agents. Indeed, for some of
these browning agents, also exemplified below, it is clear even
from a photograph of the mouse that the mouse has a fur and
hair insulation problem. This means that, in many cases, the
browning is a secondary, but necessary, consequence of the
enhanced heat loss rather than a primary molecular effect on
the browning cells themselves. Importantly, such insulation
problems cannot be sidestepped as being irrelevant additional398 Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc.effects of the browning agents: the point is that they can fully
explain both the browning and any metabolic effects. Only if
such effects are retained at the thermoneutral temperatures of
the animals exposed to browning agent would the browning
agent possess valid desirable properties for human therapy.
Some Browning Agents Are Simply Epilating
Several browning agents have the effect that the affected mice
become fully nude (full alopecia) with time. This is clearly the
case for Phospholipase C delta knockout (KO)mice that demon-
strate full hair loss (Nakamura et al., 2003) and thus expected
browning (Hirata et al., 2011) and for the Vitamin D receptor
KO, which also fully loses its hair (Li et al., 1997) and shows the
expected browning effects (Narvaez et al., 2009). The ablation
of the leucine-rich repeat containing G protein coupled receptor
4 leads at least to partial hair loss (Mohri et al., 2008) and brown-
ing (Wang et al., 2013). Also, cyclooxygenase 2 (Cox2) is a brown-
ing agent that, when specifically overexpressed in the skin, leads
to hair loss (Neufang et al., 2001). This skin-selective expression
is accompanied by white adipose tissue browning (Vegiopoulos
et al., 2010). It has been discussed that alterations in cyclooxyge-
nase products in the skin would bemolecularly transmitted to the
white adipose areas in order to induce browning (Wu et al., 2013).
However, such intricatemechanisms are probably not necessary
to explain the induced browning: the increased heat loss is prob-
ably sufficient, and the transmission is physiological.
Thus, at least for these browning agents, an a priori explana-
tion for the browning effect would be that the mice have lost in-
sulation and consequently feel as though they were exposed to
10C. Therefore, recruitment of thermogenic capacity, including
browning, is induced through the sympathetic nervous system
as it would be in wild-type animals living at 10C. This does not
exclude that cell-autonomous effects of the browning agent
may be observed (as discussed below). However, such effects
are principally of physiological or therapeutic interest only if the
browning agent maintains its beneficial properties under condi-
tions wherein the effects of the increased heat loss have been
eliminated.
Some Browning Agents Curl the Hair
There may be more subtle effects of browning agents. Some
browning agents may alter the function of the fur. These
browning agents are often fatty acid metabolism related.
Thus, mice with a KO of the stearyl CoA desaturase 1 (SCD1)
(Miyazaki et al., 2001), elongation of very-long chain fatty acids
3 (Westerberg et al., 2004), and acyl-CoA binding protein
(ACBP) (Neess et al., 2013) all demonstrate altered fur character-
istics. In such mice, browning may be observed (Sampath et al.,
2009). In agreement with the cyclooxygenase case discussed
above, a mouse with a skin-selective SCD1 KO still shows adi-
pose browning (Sampath et al., 2009). Indeed, artificial skin oc-
clusion with Vaseline eliminates the metabolic effects of an
SCD1 KO (Binczek et al., 2007) and an ACBP KO (Bloksgaard
et al., 2014; Neess et al., 2013).
In Some Cases, Available Data Implicate that Skin and
Fur Defects Could Explain Browning
In the cases above, a direct relationship between a browning
agent and skin and fur problems can be identified. In other
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instance, myostatin KO leads to browning that is not cell auton-
omous. Although other suggestions have been made (Shan
et al., 2013), it should be noted that myostatin (unexpectedly)
is expressed in the skin. Accordingly, the myostatin KO shows
decreased wound healing (Zhang et al., 2012), implying a prob-
lem in the skin of these mice. Similarly, KOs of retinaldehyde
dehydrogenase 1a1 (Kiefer et al., 2012) also induce browning.
Retinaldehyde dehydrogenases are found in the skin and hair fol-
licles (Everts et al., 2007), and their loss may affect skin insula-
tion. More intricately, the expression of FOXC2 under the aP2
promoter leads to an increased blood vessel formation under
the skin (Xue et al., 2008) and also browning (Cederberg et al.,
2001). Concerning other browning agents, such indirect indica-
tions may exist, but it is of course not possible to guess with
the use of this type of data whether the browning agent leads
to increased heat loss. A comprehensive examination of all
demonstrated browning agents with respect to insulation prob-
lems would certainly be warranted and may markedly shorten
the list of browning agents such that only true browning agents
would remain; i.e., those that cannot be explained as working
through increased heat loss.
Those We Know that We Don’t Know
The browning agents discussed above represent some of those
where information on skin or fur effects can be found in the sci-
entific literature. For many browning agents, such information is
not presently available, but an absence of data clearly does not
mean an absence of effects.
It is important to realize that we cannot, by guessing, eliminate
the risk that a browning agent works by increasing heat loss.
Who would think that a KO of protein tyrosine phosphatase 1B
would increase heat loss? But it does—it doubles it (Alberts
et al., 2006)—and this may well explain its effects on energy
expenditure, obesity, etc. (Klaman et al., 2000).
The Tale of the Tail
A possibility for an altered heat loss that is not visually obvious is
the involvement of the tail in the browning process. The tail is the
major thermoregulatory organ for heat loss in the mouse and
other rodents. When the mouse produces more heat than is
needed, the blood vessels in the tail dilate, and more heat is
lost. At normal animal house temperatures, the mouse needs to
protect itself against heat loss, and the tail blood vessels are con-
tracted. Thismeans that, if an agent canovercome the physiolog-
ical control of tail vasoconstriction and lead to vasodilation, then
heat loss will increase, and the mouse will experience conditions
akin to being exposed to a colder environment. Proof of principle
for the significance of such a process can be seen in an a1 thyroid
hormone receptormutant. Thismutant shows enhanced thermo-
genesis (Sjo¨gren et al., 2007), but this is not due to metabolic
effects of the mutation as such. Rather, the mutation causes a
loss of control of the tail blood flow, leading to increased heat
loss and thus increased thermogenesis (Warner et al., 2013).
Demonstrating the Primary Site of Action of
Browning Agents
It may correctly be advocated that the discussion above only im-
plies that it is (often) alterations in the quality of insulation (skin,fur, and blood flow) that induce browning. In none of the above
cases (except the thyroid hormone receptor mutation) has this
been directly demonstrated. Demonstrating that a browning
agent is a true browning agent necessitates demonstrating that
the effect is not secondary to insulation effects. This principally
requires that the metabolism should be studied in experiments
of the Scholander type (Figure 2), which should be performed
in order to elucidate possible loss of insulation.
In reality, all animal facilities do not possess full facilities for
such insulation experiments. However, it should not be insur-
mountable to temporarily make an animal room warmer and
examine the browning phenomenon under such conditions. If
the extent of browning is diminished, it would be a clear indica-
tion that heat loss has been an important driver of browning.
Such studies are rarely performed, although there are excep-
tions: Boon et al. (2013) found that BMP7 treatment induced sub-
stantial browning at 21C, but this effect was totally eliminated at
28C. There are several ways to interpret such results; a syner-
gistic effect between sympathetic stimulation and the browning
agent is one. However, BMP7 has been associated with the
development of hair follicles (Zouvelou et al., 2009), and Boon
et al. (2013) may thus exemplify the type of investigations that
are necessary for examining whether a skin and fur alteration
secondarily induces browning.
Early elimination of the risk that browning could be the result of
these ‘‘banal’’ heat loss effects would be quickly rewarded in that
academic or pharmaceutical enterprises would not pursue
expensive experimental avenues that have this physiological
but nonetheless secondary explanation as their background. A
prudent attitude would be to confirm that the effects are not
due to enhanced heat loss. This may significantly decrease the
number of papers reporting browning phenotypes. However, it
would perhaps provide the scientific society with some impor-
tant bona fide candidates as true browning agents.
Thermoneutrality Is Not Just 30C
For purely physical reasons, as seen in Figure 2, decreased in-
sulation will also lead to an increased lower limit of the thermo-
neutral zone from about 28C in normal mice to about 34C in
poorly insulated mice. This means that transferring mice to
30C does not necessarily lead to satisfactory elimination of
the enhanced heat loss. Thus, an observation that browning ef-
fects persist at 30C (although at a lower level) (Flowers et al.,
2011; Vegiopoulos et al., 2010) does not in itself demonstrate
that enhanced heat loss cannot explain the browning effect.
Given certain skin problems, it may even be that true thermo-
neutral conditions may not be attainable merely by increasing
the temperature even further. For example, if water permeability
is increased, then an increased temperature would lead to
higher evaporation and thus additional heat loss. Under these
conditions, sealing the skin as in Binczek et al. (2007), Bloks-
gaard et al. (2014), and Neess et al. (2013) would be able to
reduce an enhanced heat loss.
The Feeling of Cold: Reversing the Cause and Effect
The outcome of the issues discussed above is that there is a
large risk that, in browning investigations, the cause and effect
are inverted. The line of thought often presented is that the
browning agent induces more UCP1 and thus more heatCell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc. 399
Figure 3. The Vanishing Effect of DNP
Dinitrophenol (DNP) is a classical artificial mitochondrial uncoupling agent,
leading to extra heat production in practically all cells of the body. If (right-hand
bar) DNP is injected into rats at thermoneutrality, it leads to a very marked
increase in total rat metabolism (black box). However, seemingly confusingly, if
DNP is injected into rats at lower environmental temperatures, then the effect
of DNP successively disappears as the temperature is decreased (black boxes
in middle and left-hand bars). In reality, the DNP effect does not disappear.
Instead, what happens is the following: at lower temperatures, the rat has
already been forced to increase its metabolism in order to compensate for the
heat loss (red part of bars). When the extra heat induced by the DNP un-
coupling is available (and, in all cases, it is the same amount as that observed
at thermoneutrality [rightmost black box]), the rat ceases all other ongoing
thermoregulatory heat production, and there is therefore an apparently lower
effect of DNP at lower temperatures. At the lower temperatures, the body
temperature is not affected by DNP, and the rats stay euthermic. Only at
thermoneutrality is the extra heat not needed, and, if it cannot easily be
disposed of, then the rats become hyperthermic. Thus, any ‘‘extra’’ heat
production induced by exogenous activation of any process in brown fat or
browned white fat will lead to reduced thermoregulatory thermogenesis and
will, in principle, be invisible at normal animal house temperatures; only at
thermoneutrality will such an extra effect be visible, and only at thermoneu-
trality would such extra heat production lead to hyperthermia. Based on data in
Shemano and Nickerson (1958); see also Goldgof et al. (2014).
Cell Metabolism
Perspectiveproduction (and, through this, protection against obesity). For
many browning agents, the cause and effect may be the oppo-
site: the browning agent leads to decreased insulation, which
leads to increased heat loss, leading to increased need for ther-
mogenesis in order to counteract the heat loss, resulting in
browning, and the increased energy expenditure thus protects
against obesity.
Not Really Cold, but Febrile
Observations of browning are sometimes reported in connection
with reports of an increase in body temperature. This is normally
taken as an indication that the brownedwhite fat is producing ex-
tra heat and is thus functionally active. However, activation of
browning white fat—or any thermogenic process—would not a
priori be expected to result in an increase in body temperature,
particularly not in a cool environment. Mice and rats, similarly
to any mammal, are truly euthermic animals that strive to protect
their body temperature and defend a centrally determined ‘‘set
point’’ (this expression is not popular among thermal physiolo-
gists, but it remains a valid practical concept).400 Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc.Under normal laboratory conditions, protection against extra
internal heat production is easy, given that the animals (mice)
are living at a temperature where they are cold (as indicated,
20C ismuch below thermoneutrality). Any extra heat production
would be compensated by an equal reduction in thermoregula-
tory thermogenesis and thus would be visible neither in the
metabolic rate nor as an increase in body temperature. Experi-
mentally, this can be seen in experiments where heat production
is increased artificially by the classical uncoupling agent dinitro-
phenol (DNP) at different temperatures (‘‘the vanishing effect of
DNP’’). As illustrated in Figure 3, there is almost no effect on
metabolism or body temperature when DNP is injected at
‘‘normal’’ animal house temperatures. Only when injected at
thermoneutrality does DNP lead to an enhanced metabolism
and also increased body temperature when increased blood
flow in the tail cannot off load the extra heat (Shemano and Nick-
erson, 1963) (see also Golgof et al., 2014, and similar observa-
tions may be made concerning the extra heat generated during
exercise [Virtue et al., 2012]). Thus, this increase in body temper-
ature is a hyperthermia rather than a fever; i.e., it represents a
body temperature that is higher than the set point. Thus, this
body temperature is not the one preferred by the animal and is
observed only because the animal cannot dissipate the extra
heat. Thus, increases in body temperature would not be ex-
pected as an effect of browning agents under normal laboratory
conditions.
So why is an increase in body temperature often reported in
connection with browning (e.g., for fibroblast growth factor 21
[FGF21] [Coskun et al., 2008] and melatonin [Jime´nez-Aranda
et al., 2013])? We would suggest that what is observed may
not be hyperthermia but, in reality, a fever (or a pyrexia); i.e., an
increase in body temperature set point elicited by the browning
agent. A fever means that the animal will defend this higher tem-
perature even when it can easily dispose of extra heat. Results
may be obtained as those illustrated in Figure 4A wherein the
body temperature of the browning-agent-treated animal during
a circadian cycle tracks that of the untreated animal but at a
constantly higher and parallel level. It is clear that this increased
body temperature is not a hyperthermia (the mouse can clearly
decrease its body temperature during its sleeping phase). Note
that different definitions of fevers can be made; here, we use
the broadest definition; i.e., that any defended higher body
temperature represents a fever (this includes—but is not limited
to—traditional fevers of the type that are mediated by prosta-
glandins [via COX1 and COX2] and thus sensitive to aspirin
and similar drugs).
What is then the connection between browning and browning-
agent-induced fevers? A thermoregulatory mechanism could
again be relevant. Returning to the temperature/metabolism
(Scholander) diagram, it can be seen that, as a consequence
of an increase in set point, any temperature below the lower crit-
ical limit of thermoneutrality is experienced as more cold
(Figure 5). Thus, the cause and effect may also here be the oppo-
site of what is generally expressed; instead of the browning
causing the increase in body temperature (hyperthermia), the
browning is an effect of the defended increased body tempera-
ture (fever) and the ensuing feeling of being more cold at the
same environmental temperature. If examination of the mice at
a higher temperature diminishes the browning effect, then it
Figure 4. Fever, Hyperthermia, and ‘‘Revef’’
(A) Fevers (defended body temperature increases)
and ‘‘inverted fevers,’’ revefs (or anapyrexia, de-
fended body temperature decreases), are char-
acterized by keeping day and night rhythms; a
mouse showing a lowered body temperature dur-
ing the day indicates that the mouse is not forced
into an increased body temperature during the
night because of overproduction of heat caused
by, for example, a browning agent.
(B) Given that a fever is a defended increase in
body temperature, the body temperature is prin-
cipally unaffected by environmental temperature
(top curve). A hyperthermia means that the animal
cannot dispose of extra heat produced; however,
by placing the animal at a lower environmental
temperature, heat disposal will be easier and the
body temperature would become lower (middle
curve). Increases in body temperature at normal animal house temperatures are sometimes observed as an effect of a browning agent; the implication is that this
is a hyperthermia that indicates extra heat production from the browned tissue. However, under these conditions, extra heat could readily be disposed of, and an
increased body temperature is thus probably a fever induced by the browning agent. This can be tested by placing themouse acutely at lower temperatures; if the
increased body temperature is principally unaffected, then it is a fever, not a hyperthermia, indicating an effect of the browning agent on the central control of body
temperature.
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perature as being a fever is also relatively simple: the animals
should be exposed acutely to different environmental tempera-
tures (e.g., between 15C and 30C). If there is no effect of
altered ambient temperature on the increased body tempera-
ture, then it represents a fever rather than a hyperthermia
(Figure 4B). Such studies may further transfer some browning
agents to the list of secondary browning agents.
The opposite phenomenon would be evident if the browning
agent induces what may be called a ‘‘revef’’; i.e., an inverted fe-
ver (spelled backward), also referred to as an anapyrexia, that is
defended decrease in body temperature set point. Following
similar arguments, this would result in a diminished sympathetic
drive to the white adipose tissue at any given environmental tem-
perature. There are indications that, for example, FGF21 KO
leads to both a revef/anapyrexia and a diminished browning
(Fisher et al., 2012), which may thus be understandable as a
consequence of the revef.
Stress: Positive and Negative
The nerves innervating the white adipocytes are part of the sym-
pathetic nervous system. Normally, the outflow from any branch
of the system is independently controlled, and, only under con-
ditions of massively enhanced acute stress, would all sympa-
thetic nerves be activated in parallel (in sympathy). Therefore,
this stress activation may include the adipose branches.
A negative stress for a rodent would be to be suspended by a
hindlimb (Yamashita et al., 1995) or the tail (Lew et al., 2009),
immobilized (Gao et al., 2003; Harris et al., 2006; Murazumi
et al., 1987), or exposed to foot shock (McGregor et al.,
1994) or social defeat (Lkhagvasuren et al., 2011). In all these
cases, there are indications that at least the nerves to brown
fat are activated; the sympathetic nerves to white adipose tis-
sue are also most likely activated, and browning may thus be
induced.
A positive stress could be to be placed in an enriched environ-
ment, which does lead to browning (Cao et al., 2011). In general,
increased alertness will activate the sympathetic nervous sys-
tem most likely through an orexin-mediated pathway (Tuponeet al., 2011). The implication of this is that it may not be surprising
that any condition (browning agent) that may represent a gen-
eral—positive or negative—stress may also be accompanied
by browning. Although the central mechanisms underlying this
are interesting, from the browning perspective, it would seem
that this may be another example of increased sympathetic
drive being responsible for the browning process. To examine
whether this is the case, it could be investigated whether brown-
ing could be decreased by inhibition of the action of the sympa-
thetic nervous systemwith, for example, the b-adrenergic antag-
onist propranolol. This was indeed the case for the browning
effects of environmental enrichment (Cao et al., 2011). Similarly,
other browning agents may act indirectly via the brain and sym-
pathetic stimulation; e.g. thyroid hormone (T3) (Lo´pez et al.,
2010).
A natural question is what is the purpose of stress-induced
browning and brown-fat activation? It would not seem beneficial
to activate heat production and nutrient utilization under condi-
tions of stress. Perhaps there is no benefit: our Darwinian
thinking tends to make us assume that all we observe must
have a positive evolutionary explanation, but it really suffices
that the effects are not acutely detrimental. Thus, stress leads
to general sympathetic activation accompanied by increased
fighting power, and the activation of browning may merely be
an organizationally necessary but physiologically irrelevant ef-
fect of the general activation.
The Special Case of Exercise
During prolonged exercise, eating does not occur, and this
means that the energy demands for exercise must be derived
from available energy stores in the body. This would initially be
muscle energy stores (mainly glycogen), but, during more pro-
longed exercise, this would not suffice, and the energy would
necessarily have to come from the largest energy stores; i.e.,
the white-fat depots. Thus, exercise is associated with pro-
longed adrenergic stimulation of white adipose tissue depots
in order to release fatty acids to the circulation (Ranallo and Rho-
des, 1998). Therefore, it should inevitably be that browning oc-
curs during exercise, and browning is indeed observed (Bostro¨mCell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc. 401
Figure 5. The Effect of Fever on the Heat Needed to
Counteract Heat Loss at Different Temperatures
During fever, the defended body temperature is increased, as
indicated on the x axes. Physically, this means that the line
representing the insulation must be shifted to extrapolate to
the increased defended body temperature, whereas the slope
is unchanged, given that the insulation is the same. The
consequence is that, at all environmental temperatures below
thermoneutrality, the demand for extra heat production is
increased (blue versus black double arrow). Thus, if a
browning agent increases the body temperature set point (i.e.,
induces a fever), then this would lead to an increased demand
for thermoregulatory thermogenesis (blue double arrow), and
browning would occur as a response to this.
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other mechanisms may be responsible (Bostro¨m et al., 2012).
Many Browning Agents Work through Stimulating the
Sympathetic Nervous System
A conclusion from the discussion above is that many browning
agents presently described may exert their actions through indi-
rect mechanisms, leading to activation of the sympathetic ner-
vous system and thus browning, essentially through accepted
cellular mechanisms. However, this tenet has been fully experi-
mentally proven in only a few of the above cases, and it is clearly
possible that several browning agents exist that induce browning
in a unique way. However, we would consider it prudent, before
large enterprises are initiated scientifically or commercially
based on observations of induced browning, to ascertain that
the effects are not simply explainable by enhanced sympathetic
activity due to cold or stress.
The Glitazones
In addition to the adrenergic pathway discussed above, only one
alternative pathway for induction of UCP1 gene expression is
generally accepted: glitazones or thiazolidinediones (TZDs;
with rosiglitazone as the standard drug used). It is expected
that rosiglitazone utilizes a pathway of physiological signifi-
cance, but the nature of the ‘‘endogenous rosiglitazone’’ is not
known (if it exists) and neither is the physiological relevance of
this pathway. Rosiglitazone interacts with peroxisome prolifera-
tor-activated receptor g (PPARg) but does this in different ways,
both classically adipogenically and by interacting with the ability
of the Cdk5 kinase to phosphorylate PPARg (Choi et al., 2010),402 Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc.leading to other effects. It may interact with other
PPARs and also with some mitochondrial outer
(Colca et al., 2004) and inner (Divakaruni et al.,
2013) membrane proteins. It is not fully established
which of these pathways is responsible for the
browning effect. In contrast to the sympathetic ac-
tivators discussed above, stimulation of browning
by TZDs is not paralleled by an activation of the
UCP1 that is induced; i.e., stimulation by TZDs
does not in itself result in thermogenesis (UCP1 is
not leaky [Shabalina et al., 2010], but it needs
adrenergic stimulation to be activated). Given that
the TZD effectors may be rather broad in their
ligand requirements, it is not unlikely that several
of the food substances reported to induce brown-ing may use the TZD system (e.g., bofutsushosan [Akagiri et al.,
2008], scallop shell powder [Liu et al., 2006], and several others).
Given that the intracellular mechanism mediating browning by
TZDs is not fully established, it is not straightforward to examine
whether novel browning substances hijack the TZD pathway, but
the effect of PPARg antagonists could at least be tested before
novel pathways are implied.
Are There Stimuli that Selectively Induce Browning?
The above discussions would imply that browning of white adi-
pose tissue would always be paralleled by (or preceded by)
recruitment of classical brown adipose tissue because of the
hierarchical stimulatory arrangement of the sympathetic nervous
system. Such browning agents may be considered to be of less
principal interest than putative browning agents that selectively
induce browning without recruiting brown adipose tissue.
In the—at the time, probably comprehensive—listing of
browning agents presented by Wu et al. (2013), the authors
meticulously tabulate 65 agents that induce browning. Then,
they ask the important question of whether any of these agents
selectively browns white adipose tissue or whether the browning
is paralleled by recruitment of classical brown adipose tissue
(i.e., in line with the hierarchical activation discussed above).
Wu et al. (2013) conclude that only four agents have been re-
ported to selectively induce browning: 4E-BP1 KO, IKKε KO,
Cox2 skin overexpression, and TRPV4 antagonism (for another
seven browning agents, brown adipose tissue was not exam-
ined). Examining the four studies, the impression gained is that
even these exceptions have not been extensively corroborated;
for the 4E-BP1 KO, only unchanged brown adipose tissue wet
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IKKε, unchanged brown adipose tissue UCP1mRNA and protein
levels (see below) (Chiang et al., 2009); for Cox2 skin overexpres-
sion, brown adipose tissue UCP1 mRNA levels were (only)
doubled (see below) (Vegiopoulos et al., 2010); and, for TRPV4
antagonism, brown-fat UCP1 mRNA levels were unchanged
(Wu et al., 2012).
In investigations of browning, it is often reasoned that, if a
given browning agent induces UCP1 mRNA levels many-fold in
white fat but has (nearly) no effect on UCP1 mRNA levels in clas-
sical brown adipose tissue, then the effect in white fat must be
the important one. However, starting from mice at normal tem-
peratures, brown adipose tissue recruitment may not reveal a
(dramatic) increase in UCP1 mRNA levels nor even in UCP1 pro-
tein per milligram tissue protein. This is because, in mice living at
normal animal house temperatures, these parameters are
(nearly) saturated already, given that the tissue is already stimu-
lated by the cold environment (Nedergaard and Cannon, 2013).
For the tissue to increase its thermogenic capacity, it must
expand its active mass; i.e., through increased cell proliferation
and differentiation. Thus, only if the total amount of UCP1 protein
in the whole tissue is monitored can it be concluded whether
classical brown adipose tissue is also recruited. In white depots,
large relative increases in, for example, UCP1 mRNA levels do
occur, but levels start from absolute values of UCP1 mRNA
that are some 100- to 1,000-fold lower than those in brown adi-
pose tissue (Nedergaard and Cannon, 2013). Thus, a small rela-
tive increase in classical brown adipose tissue thermogenic
markers may thermogenically outclass a large relative increase
in the thermogenic markers of browning white adipose tissue.
Are the Metabolic Effects Really Caused by Browning?
Concerning the browning agents, reasoning is often forwarded
as follows: browning agent X has metabolic effects (increases
thermogenesis, makes the mouse slimmer, etc.), and browning
agent X browns white adipose tissue; therefore, browning agent
X makes mice slim because of browning in white fat. Clearly
there could be other reasons for the metabolic effects than
browning; it should be realized that many metabolic effects
caused, for example, by decreased insulation would principally
occur irrespective of whether brown-fat recruitment and brown-
ing took place or not. However, except for the browning induced
by cold (Golozoubova et al., 2001) or high-fat diet (Feldmann
et al., 2009), involvement of UCP1 in the metabolic effects has
not been proven for any browning agent, and, in the cases of
cold and high-fat diet, it is very likely primarily the UCP1 in the
classical brown-fat depots that is quantitatively responsible for
the metabolic effects.
To establish whether indeed browning is responsible for the
phenomenon of interest, the metabolic effect should disappear
if browning is prevented; i.e., mice should be engineered that
do not express UCP1 specifically in the white adipose tissue de-
pots. Such mice are not available today and would in any case
probably not provide an unequivocal answer, given that
compensation in other adipose depots would probably occur
(cf. the compensation found in the myf5-BMPR1-KO mice)
(Schulz et al., 2013). Given that this experimental approach not
is avaiable, the necessity of UCP1 for the effect should at least
be demonstrated. This is readily possible given that UCP1 KOmice exist (Enerba¨ck et al., 1997) and are commercially avail-
able. However, there can be some interpretation problems in
the use of UCP1 KOmice. At normal animal house temperatures,
UCP1 KO mice unexpectedly do not become more obese than
controls, and, at this temperature, they are actually ‘‘protected’’
against the effects of obesogenic diets (Liu et al., 2003) (the
reason for this effect is not clarified but may be related to the
stress that the absence of nonshivering thermogenesis causes
for mice living in the cold). Thus, the obesogenic effect of the
absence of UCP1 is observed only at thermoneutrality (Feld-
mann et al., 2009). The experiment would then be to test the
browning agent in UCP1 KO mice kept at thermoneutrality; if
the slimming effect were to disappear, then it could at least be
concluded that it was due to UCP1 activation (although the site
could not be established through this).
Apparent, but Flawed, Increases in Metabolism
In many studies reporting slimming effects of browning agents,
one of themain arguments that the slimming is due to the brown-
ing of white adipose tissues and the ensuing increased thermo-
genic capacity is data showing elevated mouse metabolism
(oxygen consumption). However, it may often be observed that
the metabolic data in these reports are obtained by dividing
the metabolic rate (oxygen consumption) of each mouse by its
total body weight (sometimes to the power of 0.75 or 0.66, but
this does not alter the outcome). Given that obese and ‘‘normal’’
mice basically differ only in the amount of chemical triglycerides
they have accumulated, the amount of metabolically active
‘‘lean’’ tissue is generally not different between slim and obese
mice. This means that using total body weight as the divisor
will result in an erroneous contribution to metabolism from
chemically inert triglycerides, and this means that, with actual
unchanged metabolism between obese and slim animals, the
slim mice would appear to demonstrate an increased meta-
bolism. This pseudophenomenon has been commented repeat-
edly over the years (Butler and Kozak, 2010; Cannon and Neder-
gaard, 2011; Himms-Hagen, 1997; Tscho¨p et al., 2012). The
simplest way to avoid this problem is to express metabolism
per total mouse (not dividing by anything); this is again because
most browning agents only induce marginal alterations in the
amount of metabolically active tissue (lean body weight). If
data for body composition are available (e.g., through MRI anal-
ysis), then a more adequate procedure is to express the values
per lean body weight (or lean body weight to the 0.75 power).
Even when adequately presented in this respect, the logic of
cause and effect may easily become inverted. If the browning
agent leads to an enhanced heat loss (as many do, as discussed
above), any metabolic data collected at temperatures below
thermoneutrality demonstrate only the stimulation of thermogen-
esis necessary to balance the heat loss and are not indications of
free-running, agent-induced overproduction of heat. Only if an
enhanced metabolic rate, that had been adequately calculated,
were observable at thermoneutrality would it be evidence that
the browning agent actually induced an overproduction of
heat. We are currently not aware of any of the browning agents
having been demonstrated to induce increased metabolism
when analyzed in this way. This does not mean that this could
not be possible. Even small but chronically maintained increases
in metabolic rate, too small to be detected reliably in presentCell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc. 403
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development of obesity.
The Relationship between Slimming and Browning
Reports on many browning agents include data indicating that
the agent also induces slimming, the implication being that it is
the browning that causes the slimming. Again, considering
enhanced heat loss as a possible cause of browning, an alter-
native scenario would be that the browning agent, through
some other mechanism, causes slimming. It is generally
assumed that increased fat layers (particularly in the subdermal
or subcutaneous adipose depots) have an insulating effect,
although convincing mouse data on this seem to be missing.
If this is the case, then slimming would lead to increased heat
loss under subthermoneutral conditions, and this increased
heat loss would then be the driving force for the browning of
the white adipose tissue. Again, this important distinction can
only be made when heat loss is not a problem; i.e., by perform-
ing the experiments at the thermoneutral temperature of the
treated mouse.
Furthermore, it could be expected that any increased meta-
bolism in the cold would be compensated by increased food
intake (i.e., that leptin or another adipostat mechanism would
ensure sufficiently increased appetite to maintain body energy
reserves). However, it appears that cold is to some extent
exempt from the adipostat effect (discussed in Cannon and Ne-
dergaard, 2009), even though we do not understand why the ex-
tra energy combusted in the cold is not fully compensated.
Therefore, observations that animals that experience a brown-
ing-agent-induced increased cold stress (as discussed above)
become slimmer should not be considered as indicative of a spe-
cial action of browning agents.
Slimming is the result of degradation of triglycerides stored in
white adipose tissue and combustion of the liberated fatty acids.
Whereas the concept that UCP1 in the browning white adipose
tissue could be the site of combustion is appealing, there is no
a priori reason to presume that the combustion should take place
directly in the white adipose tissue. Just as is the case during
prolonged exercise (Ranallo and Rhodes, 1998), the fatty acids
needed for combustion could equally well be transported to
the energy-utilizing organ. During exercise, this would bemuscle
and, during cold exposure, it would be, to a high degree, brown
adipose tissue. There are several observations that indicate that
brown adipose tissue is well endowed to take up fatty acids from
the circulation for combustion in the classical brown-fat mito-
chondria (Henkin et al., 2012; Wu et al., 2006).
Cell-Autonomous or Central
In the discussions above, the implication has been that browning
may often be the result of central effects; i.e., that a browning-
agent-induced increase in sympathetic stimulation can explain
the browning in the white adipose tissue. However, many brown-
ing agents have been shown to have cell-autonomous effects;
i.e., when added to cell cultures consisting of real adipocytes
or of cell lines, they induce effects that can be understood in
terms of browning. The interpretation of such studies has
some complications.
The expression of UCP1 is not spontaneous in any brown or
white fat cell. Although we think of brown adipose tissue as a404 Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc.tissue in which UCP1 is found, brown-fat precursor cells isolated
from brown adipose tissue and grown in culture to adipocyte
maturity express essentially no UCP1, nor do white-fat precur-
sors (‘‘essentially’’ means some 100- to 1,000-fold lower UCP1
mRNA levels than in active brown fat). However, when such cul-
tures are stimulated with norepinephrine, a large increase in
UCP1 mRNA levels is induced in both brown- and white-fat cells
by some 100-fold (absolute levels in white fat do not reach those
in brown fat, even if the increases are relatively larger, given that
they start from lower levels) (Petrovic et al., 2008, 2010). In vivo,
the browning process induced by cold similarly increases UCP1
mRNA levels in white adipose tissue by some 100-fold (Walde´n
et al., 2012).
These relative increases may be contrasted to the increases
in UCP1 gene expression reported to be induced by many
browning agents in cell culture studies. These increases are
often statistically robust, but their absolute levels are often
much lower than those induced by norepinephrine (or in the
cold) and are often also much lower than what is observed
in vivo by the same browning agent. In order to eliminate the
risk of unspecific effects and be potentially physiologically sig-
nificant, cell-autonomous effects would be expected to be
close to those that can be induced by norepinephrine. To our
knowledge, none or few of the presently tested browning
agents fulfill such criteria. An ‘‘explanation’’ for these modest
cell-autonomous effects could be that some of the agents
interact with noncognate receptors, are therefore only partial
agonists, and thus can only induce minor effects. Additionally,
even if a browning agent shows robust effects in cell culture,
the physiologically and therapeutically relevant question must
still be whether a metabolic effect is observable in vivo at ther-
moneutrality, a property not demonstrated for any browning
agent presently.
Concerning functional analysis of the browned cells, their ther-
mogenic capacity, their possible specific roles, their origin, and
the nature of human UCP1-containing cells, a short summary
can be found in the Supplemental Information.
The Burning Issues
This Perspective has reviewed and pointed to some burning
issues, mainly whether many of the browning results reported
are secondary, being due to activation of the sympathetic ner-
vous system, because heat loss has been increased.
If we require a true browning agent to (1) function through
other mechanisms than those affecting heat loss, (2) lead to
increased metabolism at thermoneutrality, (3) lead to decreased
obesity, and (4) do this without recruiting classical brown adi-
pose tissue, then it would seem that no true browning agent
has been fully verified to date. Some of those suggested may
eventually achieve this status, but there are presently no un-
equivocal candidates.
Concerning the consequences of the browning effect itself,
there is presently (see the Supplemental Information) no
consensus that browned white adipose tissue possesses phys-
iological functions qualitatively different from those of classical
brown adipose tissue or that the tissue is regulated in a way dis-
tinguishing it principally from classical brown adipose tissue. The
quest for true browning agents, and exclusive browning effects
may therefore go on.
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